What is Abacavir-dolutegravir-lamivudine?

Category: Prescription Drugs


See also: Abacavir (ABC) Dolutegravir Lamivudine

Abacavir-dolutegravir-lamivudine is a combination product intended to treat HIV/AIDS.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Abacavir-dolutegravir-lamivudine

Side effect Patients


Based on patients currently taking Abacavir-dolutegravir-lamivudine

Dosage Patients
600-50-300 mg daily 1

Why patients stopped taking Abacavir-dolutegravir-lamivudine

Multiple reasons could be selected

Reason Patients
Doctor's advice 1
Other 1
See 1 patient who's stopped taking Abacavir-dolutegravir-lamivudine


Currently taking Abacavir-dolutegravir-lamivudine

Duration Patients
2 - 5 years 1

Stopped taking Abacavir-dolutegravir-lamivudine

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 0

What people switch to and from

Patients stopped taking Abacavir-dolutegravir-lamivudine and switched to:

Treatment Patients
Triumeq 1
Last updated:
There are no evaluations for Abacavir-dolutegravir-lamivudine.